Management is buying the same thing twice: proven demand from one place is being replicated into identified new places r
The model's full reasoning — Q3 2018 call → NOWe need answer only YES or NO based on transcript. Need determine if management describes current middle of copying proven business into additional places with demand visible. Let's analyze. Company Myomo: sells MyoPro orthosis for upper limb paralysis. They are scaling up commercialization. They opened new sales regions by hiring business development managers and clinical support staff. These professionals recruited and trained O&P clinics to provide MyoPro. Then local digital marketing campaigns and patient screening days. In quarter added six new O&P providers, total 13 locations in metro areas including Atlanta, Sacramento, Seattle. Continue expand distribution footprints. Screening days from 12 Q1 to 25 Q2 to 100 Q3. Reimbursement pipeline 222 units. Adding around 40 new patients per month. Sold 94 units in all 2017. Also expanding to adolescents, children's hospitals, AFM. Testing prototypes pediatric device. International expansion: signed O&P provider in Denmark, conducted screening days in UK, began calling potential distributors. Question: Does management describe company as CURRENTLY IN MIDDLE OF COPYING A PART OF ITS OWN BUSINESS THAT IS ALREADY WORKING INTO ADDITIONAL PLACES WHERE SAME DEMAND IS ALREADY VISIBLE? Need identify proven instance: U.S. sales and marketing model? They have proven sales regions? They are replicating by hiring BDM and clinical support, recruiting O&P clinics, running screening days. They have record 130 new patients entering reimbursement process. Pipeline 222 units. They are adding new O&P providers in metro areas. Demand visible? They have screening days with patient prospects. They are adding locations where demand already visible? They mention "local digital marketing campaigns and hosted patient screening days to evaluate patients" - so demand is generated. But is demand already identified at destination? They are expanding to new regions with O&P providers. They have "new own key providers" certified. They are aiming at demand they can see? They have screening days with patients. But is it "demand already visible" like waitlists or unserved orders? They have pipeline of 222 units representing potential revenue. But that's overall, not necessarily at new locations. They are adding new O&P providers in metro areas. They likely have patient prospects from marketing.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| BRBR | BellRing Brands, Inc. | Q4 2023 | 2023-11-21 | B+ |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| VSEC | VSE Corporation | Q3 2022 | 2022-10-28 | B+ |
| FSLR | First Solar, Inc. | Q3 2022 | 2022-10-28 | C+ |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| GDS | GDS Holdings Limited | Q2 2021 | 2021-08-17 | C+ |
| TPIC | TPI Composites, Inc. | Q3 2018 | 2018-11-11 | C |
| ALB | Albemarle Corporation | Q3 2018 | 2018-11-08 | B |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| FOLD | Amicus Therapeutics, Inc. | Q1 2018 | 2018-05-08 | C+ |
| AOSL | Alpha and Omega Semiconductor Limited | Q2 2018 | 2018-02-07 | B |
| VSAT | Viasat, Inc. | Q4 2017 | 2017-05-23 | C+ |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
GDS · Q2 2021 → YESThe question is whether management describes the company as currently in the middle of copying a part of its own business that is already working into additional places where the same demand is alread...YES The transcript shows management describing a clear, present-tense replication of their proven China-based data center platform into new markets (Hong Kong, Macau, Southeast Asia) where demand is already visible and committed. William Huang explicitly references the “proven” China edge-of-town model (land-and-expand MOUs, 500 000 sqm secured pipeline, hyperscale orders already landed) and states they are “currently developing two purpose-built data centers” in Hong Kong (HK1/HK2) with most capacity “already allocated to strategic customers pending contracts,” plus a new building (HK4) under agreement and a heads-of-agreement for HK3, creating “nearly 80 megawatts of purpose-built capacity through to 2027.” For Macau they have a JV to acquire brownfield sites for redevelopment (20 MW).
FOLD · Q1 2018 → YESThe question is about whether management describes the company as currently copying a proven part of its business into additional places where demand is already visible. YES The transcript shows management describing Galafold as a proven commercial offering (Q1 revenue $16.7M, 300% YoY growth, hundreds of patients, high compliance, 7 approvals, 18 countries with pricing/reimbursement) that is now being replicated into additional markets.
TPIC · Q3 2018 → YESThe question is whether management describes the company as currently in the middle of copying a part of its own business that is already working into additional places where the same demand is alread...YES The transcript shows management describing a proven manufacturing operation (existing dedicated lines and plants in the U.S.